SCHEMBL24508124

SCHEMBL24508124

CC(C)NC(=O)CCOCCOCCOCCC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
FAAH O00519 1/20 0.41
MAPK1 P28482 1/20 0.41
HPGD P15428 2/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
NLRP1 Q9C000 1/20 0.35
CHRM5 P08912 1/20 0.33
CHRM3 P20309 1/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 3/20 0.32
CYP3A4 P08684 1/20 0.32
NFKB1 P19838 1/20 0.32
ADRA1A P35348 1/20 0.32
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26364046 1.00 MEN1 (0.41) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL25884119 0.98 MEN1 (0.42) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL24926079 0.90 MEN1 (0.42) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL24193648 0.88 MEN1 (0.43) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL19703895 0.87 SIGMAR1 (0.37) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL20325951 0.87 MEN1 (0.42) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL14296209 0.86 MEN1 (0.41) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL15396215 0.86 MEN1 (0.41) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL20469928 0.86 MEN1 (0.42) MEN1KMT2AFAAHMAPK1HPGD
SCHEMBL23913185 0.85 SMN1; SMN2 (0.34) HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185808-A1 ACYLAMINOPYRROLO-PYRIDONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI RINGENE BIOPHARMA CO., LTD. (CN) 2022-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185808-A1 ACYLAMINOPYRROLO-PYRIDONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF CYP4F11, CYP4A11, AASDHPPT MEN1 1088/4885KMT2A 3778/4885FAAH 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.